Sharescart Research Club logo
Apollo Green 72 (28.6%)ASK Investment 895 (-3.2%)AVPL 49 (0%)Bootes Impex 775 (-8.8%)CIAL 442 (-0.5%)CSK 254 (-3.1%)ESDS Software 478 (2.8%)Garuda Aerospace 468 (-2.1%)Goodluck Defence 385 (16%)Hero Motors 325 (0%)Hinduja Leyland 248 (0%)ICL Fincorp 25 (0%)Incred Holdings 154 (2.7%)Kineco Limited 3285 (0%)Lava 60 (15.4%)Market Simplified 26 (-7.1%)Matrix Gas 12 (-20%)Motilal Oswal 12.25 (-2%)MSEI 6.35 (-2.3%)NCDEX 368 (-1.6%)NSE 1985 (-2%)Onix Renewable 68 (21.4%)OYO 23 (-4.2%)OYO Assets 9.25 (-7%)Philips India 1250 (0%)Polymatech Electronics 56 (-3.4%)SBI Mutual 768 (-0.9%)Taparia Tools 6050 (0%)VCI Chemical 64 (0%)Zepto 40 (-4.8%)

15 Days Price Change

Neochem Bio Solution IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size 32.2 Cr
Profile
Price Range 93  to  98 per share
Profile
Min Investment ₹98
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

We are a specialty performance chemical company with a legacy of over four decades, engaged in the businessof manufacturing specialty performance chemicals with a diverse portfolio of over 350 customized formulationsacross four primary product segments viz.,(i) Polymers, (ii) Surfactants, (iii) Silicones, and (iv) Esters & biobasedsustainable solutions. Our products are essential and used in industries such as textile & garment washing,home & personal care (HPC), institutional and industrial cleaners, water treatment, paints and coatings, paper andpulp, construction, rubber and dyes and pigments. Our Company is accredited with recognized processcertifications such as ISO 9001:2015, ISO 14001 and ISO 45001. Our product certifications include ZDHC Level3 and GOTS 7.0. Read More

Basic Info

Face Value 10 per share

Price 93  to  98 per share

P/E (x) 14.8

Sales( Cr.) 84

PAT( Cr.) 8

EPS 6.6

Draft Prospectus

Exchange NSE-SME

Promoter

Company Promoters

Swapnil Rameshbhai Makati Hemangini Swapnil Dathia

Pre Issue Share Holding 91.12%

Post Issue Share Holding 66.7%

Listing Details:

Listing Price: 108

Listing Gain: 9.26%

Current Price: 106

Gain On Issue: 106 | 0%

GMP: 2

GMP %: 2 %

IPO Tentative Timetable

Opening Date Dec 02, 2025
Closing Date Dec 04, 2025
Allotment Dec 05, 2025
Refund Dec 08, 2025
Delivery of Shares Dec 08, 2025
Listing Date Dec 09, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 2400 235,200
Retail (Max) -- -- --
S-HNI (Min) 1 2400 235,200
S-HNI (Max) 4 9600 940,800
B-HNI (Min) 5 12000 1,176,000

Objective of the Issue

1. Funding the long-term working capital requirements of the Company.2. Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by our Company.3. General Corporate Purposes.

Issue

Category Nos Bid Bid (x)
QIB 0 19142400 0x
NII 0 14088000 0x
Retail 0 14376000 0x
EMP 0 0 0x
Total 0 47606400 0x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Neochem Bio Solution Profit & Loss

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 48 61 84
Other Income 1 1 2
Total Income 49 62 86
Total Expenditure 44 55 71
Operating Profit 5 7 15
Interest 2 3 4
Depreciation 1 1 1
Exceptional Income / Expenses 0 0 0
Profit Before Tax 2 3 10
Provision for Tax 0 1 3
Profit After Tax 1 2 8
Adjustments 0 0 0
Profit After Adjustments 1 2 8
Adjusted Earnings Per Share 1.1 1.5 6.6

Neochem Bio Solution Balance Sheet

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 8 12 20
Minority's Interest 0 0 0
Borrowings 12 18 14
Other Non-Current Liabilities 1 1 1
Total Current Liabilities 29 33 44
Total Liabilities 51 64 79
Fixed Assets 15 19 19
Other Non-Current Assets 4 7 7
Total Current Assets 32 39 53
Total Assets 51 64 79

Neochem Bio Solution Cash Flow

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0
Cash Flow from Operating Activities -1 2 3
Cash Flow from Investing Activities -3 -8 -2
Cash Flow from Financing Activities 4 6 -1
Net Cash Inflow / Outflow -0 0 -0
Closing Cash & Cash Equivalent 0 0 0

Neochem Bio Solution Ratios

# Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 1.13 1.54 6.64
CEPS(Rs) 2.41 2.59 7.77
DPS(Rs) 0 0 0
Book NAV/Share(Rs) 8.48 10.27 16.91
Core EBITDA Margin(%) 8.77 9.8 15.58
EBIT Margin(%) 7.5 9.21 16.35
Pre Tax Margin(%) 3.15 4.37 12.19
PAT Margin (%) 2.23 2.95 9.21
Cash Profit Margin (%) 4.75 4.94 10.79
ROA(%) 2.12 3.14 10.84
ROE(%) 13.33 17.96 48.82
ROCE(%) 10.54 14.15 27.34
Receivable days 109.19 94.48 92.18
Inventory Days 113.09 98.91 90.99
Payable days 156.95 130.08 100.44
PER(x) 0 0 0
Price/Book(x) 0 0 0
Dividend Yield(%) 0 0 0
EV/Net Sales(x) 0.66 0.65 0.5
EV/Core EBITDA(x) 6.55 5.79 2.8
Net Sales Growth(%) 0 26.89 37.66
EBIT Growth(%) 0 55.86 144.44
PAT Growth(%) 0 67.89 330.28
EPS Growth(%) 0 36.48 330.28
Debt/Equity(x) 3.26 2.78 1.8
Current Ratio(x) 1.09 1.17 1.21
Quick Ratio(x) 0.58 0.62 0.67
Interest Cover(x) 1.72 1.9 3.93
Total Debt/Mcap(x) 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 38% 0% 0% 0%
Operating Profit CAGR 114% 0% 0% 0%
PAT CAGR 300% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 49% 27% 27% 27%
ROCE Average 27% 17% 17% 17%

Company Contact Information

Neochem Bio Solutions Ltd.

Shradha Sarthak Agarwal

+91 079 35217792

compliance@neochem.in

303, W1, Opp. Vikramnagar Colony Off. Iscon- Ambli Road Ambli Daskroi

IPO Lead Manager(s)

Neochem Bio Solutions Ltd.

Vivro Financial Services Pvt Ltd

Registrar Info

Neochem Bio Solutions Ltd.

MUFG Intime India Pvt Ltd.

C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai (Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra

+91 810 811 8484

91-022-49186060

rnt.helpdesk@in.mpms.mufg.com

https://in.mpms.mufg.com/

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp